PUMA BIOTECHNOLOGY, INC. — Director's Dealing 2011

Oct 11, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PUMA BIOTECHNOLOGY, INC. (NONE)
CIK: 0001401667
Period of Report: 2011-10-06

Reporting Person: AUERBACH ALAN H (Director, PRESIDENT, CEO & SECRETARY, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-10-06	COMMON STOCK	A	40000	—	Acquired	4040000	Direct

Footnotes

F1: Reflects shares acquired through the conversion of a convertible promissory note (the "Note") issued in favor of the Reporting Person on September 9, 2011 in the principal amount of $150,000. The Note was converted into 40,000 shares of common stock of the Issuer at a conversion price of $3.75 per share. The number of shares and exercise price were not fixed until conversion.